Published in Cardiovasc Clin on January 01, 1985
New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice. Arch Intern Med (2000) 2.00
Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group. Circulation (1995) 1.82
Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators. Circulation (1994) 1.67
Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome : direct evidence from intracellular recordings in the intact left ventricular wall. Circulation (2001) 1.50
Things that go bang in the night. N Engl J Med (1992) 1.43
Fast Fourier transformation of the entire low amplitude late QRS potential to predict ventricular tachycardia. J Am Coll Cardiol (1989) 1.40
A broken heart. Circulation (1998) 1.32
Cardiopulmonary bypass. Associated hemostatic abnormalities. J Thorac Cardiovasc Surg (1979) 1.31
Early ischemia after complete coronary ligation in the rabbit, dog, pig, and monkey. Am J Physiol (1981) 1.13
Cyclosporine in cardiac transplantation. Surg Clin North Am (1985) 1.11
Tumors of the small intestine. Curr Probl Surg (1980) 1.08
Ventricular hypertrophy amplifies transmural repolarization dispersion and induces early afterdepolarization. Am J Physiol Heart Circ Physiol (2001) 1.07
T-wave abnormalities of intermittent left bundle-branch block. Ann Intern Med (1978) 1.04
Left ventricular hypertrophy decreases slowly but not rapidly activating delayed rectifier potassium currents of epicardial and endocardial myocytes in rabbits. Circulation (2001) 1.03
Effect of whiskey on atrial vulnerability and "holiday heart". J Am Coll Cardiol (1983) 1.00
Central hypotensive activity of dl- and d-propranolol. J Pharm Sci (1970) 0.99
Tachycardia upon swallowing. Evidence for a left atrial automatic focus. J Electrocardiol (1976) 0.97
The "R-on-T" phenomenon: an update and critical review. Ann Intern Med (1978) 0.97
Assessment of exercise oxygen consumption as preoperative criterion for lung resection. Ann Thorac Surg (1987) 0.94
Generic antiarrhythmics are not therapeutically equivalent for the treatment of tachyarrhythmias. Am J Cardiol (2000) 0.93
Histopathologic factors conducive to experimental ventricular tachycardia. Surgery (1985) 0.92
Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol (1998) 0.91
The calamity of cardioversion of conscious patients. Am J Cardiol (1988) 0.90
The head-up tilt table test and cardiovascular neurogenic syncope. Am Heart J (1993) 0.90
A case of being scared to death. Arch Intern Med (1983) 0.89
Knotting of a flow-directed catheter about a cardiac structure. Cathet Cardiovasc Diagn (1977) 0.88
Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness, and vulnerability to inducible ventricular fibrillation. Circulation (1997) 0.86
Effect of age on the cardiotoxic action of digitalis. J Pharmacol Exp Ther (1976) 0.86
Sustained haemodynamic action of nitroglycerin ointment. Br Heart J (1976) 0.86
Transient right bundle branch block with "Swan-Ganz" catheterization. Am Heart J (1976) 0.86
Management and prevention of atrial fibrillation after cardiovascular surgery. Am J Cardiol (2000) 0.86
Acute torsion of the gallbladder: review of the literature and report of a case. Am Surg (1976) 0.85
The influence of prostacyclin on coronary occlusion induced arrhythmia in cats. Prostaglandins Med (1979) 0.85
Electrophysiological changes in the rat atrium with age. Am J Physiol (1974) 0.85
Influence of mixed venous oxygen tension (PVO2) on blood flow to atelectatic lung. Anesthesiology (1983) 0.85
Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery. Circulation (1999) 0.84
Electrophysiologic effects of hydralazine on sinoatrial function in patients with sick sinus node syndrome. Am J Cardiol (1978) 0.84
Arrhythmias and social drinking. Ann Intern Med (1983) 0.84
Changes in vagal activity and response to muscarinic receptor agonists with age. J Gerontol (1980) 0.84
Effect of left ventricular hypertrophy and its regression on ventricular electrophysiology and vulnerability to inducible arrhythmia in the feline heart. Circulation (1995) 0.84
Dispersion of atrial refractoriness in patients with sinus node dysfunction. Circulation (1979) 0.84
Cardiac abnormalities in primary hemochromatosis. Ann N Y Acad Sci (1988) 0.83
Sustained arrhythmias in hypertrophic obstructive cardiomyopathy. N Engl J Med (1984) 0.83
Nonarrhythmogenicity of therapeutic cryothermic lesions of the myocardium. J Surg Res (1985) 0.83
Propranolol in mitral stenosis during sinus rhythm. Am Heart J (1977) 0.82
Giant sigmoidal diverticulum: report of a case and review of the literature. Dis Colon Rectum (1978) 0.82
Effect of transmural versus nontransmural myocardial infarction on inducibility of ventricular arrhythmias during sympathetic stimulation in dogs. J Am Coll Cardiol (1988) 0.81
Digitalis in the sick sinus syndrome. The effects of digitalis on sinoatrial automaticity and atrioventricular conduction. Circulation (1973) 0.81
Vulnerability to ventricular fibrillation in patients with clinically manifest ventricular tachycardia. Am Heart J (1984) 0.81
Nonuniform cardiac sympathetic nerve discharge: mechanism for coronary occlusion and digitalis-induced arrhythmia. Circulation (1978) 0.81
The properties of the inward rectifier potassium currents in rabbit coronary arterial smooth muscle cells. Pflugers Arch (1999) 0.81
The effect of d(+)- and 1(-)-practolol on ouabain-induced arrhythmia. Eur J Pharmacol (1972) 0.81
INVEST substudies: design and patient characteristics. Clin Cardiol (2001) 0.81
Effect of antiarrhythmic drugs on defibrillation threshold: case report of an adverse effect of mexiletine and review of the literature. Pacing Clin Electrophysiol (1988) 0.81
Effects of oral propafenone on defibrillation and pacing thresholds in patients receiving implantable cardioverter-defibrillators. Propafenone Defibrillation Threshold Investigators. J Am Coll Cardiol (1996) 0.80
First-degree sinoatrial heart block: sinoatrial block in the sick-sinus syndrome. Am Heart J (1976) 0.80
Effects of digitalis on atrial vulnerability. Am J Cardiol (1978) 0.80
Role of adrenergic influences in digitalis-induced ventricular arrhythmia. Life Sci (1976) 0.80
Bioavailability of amiodarone tablets administered with and without food in healthy subjects. Am J Cardiol (2001) 0.80
Influence of intracoronary platelet aggregation on ventricular electrical properties during partial coronary artery stenosis. Am J Cardiol (1983) 0.80
Regression of LV hypertrophy with captopril normalizes membrane currents in rabbits. Am J Physiol (1998) 0.79
Atrial arrhythmias after cardiac surgery: Sisyphus revisited? J Am Coll Cardiol (1999) 0.79
Clinical and regulatory implications of the Cardiac Arrhythmia Suppression Trial. Am J Cardiol (1990) 0.79
Mediation of cardiac ischemia by thromboxanes released from human platelets. Surgery (1982) 0.79
Effect of sulfinpyrazone on ventricular arrhythmia, prostaglandin synthesis, and catecholamine release following coronary artery occlusion in the cat. J Cardiovasc Pharmacol (1983) 0.79
ST segment elevation and sudden cardiac death: from the Brugada syndrome to acute myocardial ischemia. J Cardiovasc Electrophysiol (2000) 0.79
Ventricular fibrillation during coronary angiography: the precatheterization QT interval. J Electrocardiol (1987) 0.79
Ventricular extrastimulation in the mitral valve prolapse syndrome. Evidence for ventricular reentry. J Electrocardiol (1978) 0.79
Dose-related haemodynamic effects and pharmacokinetics of oral nicorandil in patients evaluated for chest pain. Int J Cardiol (1994) 0.79
Gender differences in device therapy for malignant ventricular arrhythmias. Arch Intern Med (1995) 0.79
Histamine 2 receptor antagonism by cimetidine and sinus-node function. N Engl J Med (1979) 0.79
Diagnostic implications of atrial vulnerability. Pacing Clin Electrophysiol (1979) 0.78
Increased normoxic-to-ischemic tissue borderzone as the cause for reentrant ventricular tachyarrhythmias. J Surg Res (1982) 0.78
The effect of propranolol and quinidine on 22 Na- and 42 K-exchange in the cat papillary muscle. Eur J Pharmacol (1972) 0.78
Modulation of arachidonic acid metabolites and vulnerability to ventricular fibrillation during myocardial ischemia in the cat. Am Heart J (1988) 0.78
Repolarization abnormalities in mitral valve prolapse. Am Heart J (1987) 0.78
Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study. Diabetologia (2005) 0.78
A study of the antiarrhythmic action of certain beta-blocking agents. Am Heart J (1974) 0.78
Appraisal of sinus node artery disease. Circulation (1975) 0.78
Adrenergic innervation of the heart as a site for the genesis and control of arrhythmia. Recent Adv Stud Cardiac Struct Metab (1973) 0.78
Restoration of normal ventricular electrophysiology in renovascular hypertensive rabbits after treatment with losartan. J Cardiovasc Pharmacol (2001) 0.78
A statewide system to track medical students' careers: the Pennsylvania model. Acad Med (1999) 0.77
The repetitive extrasystole as an index of vulnerability to ventricular fibrillation during myocardial ischemia in the canine heart. Am Heart J (1983) 0.77
Arrhythmia inducibility and ventricular vulnerability in a chronic feline infarction model. Am Heart J (1985) 0.77
Arrhythmias from fiberoptic bronchoscopy. Chest (1978) 0.77
Pharmacologic modification of myocardial ischemia. Circulation (1982) 0.77
Potassium channels in cardiac arrhythmias: focus on antiarrhythmic drug action. Prog Clin Biol Res (1990) 0.77
Tachycardia-aggravated heart disease. Ann Intern Med (1974) 0.77
Influence of the adrenal medulla on cardiac rhythm disturbances following acute coronary artery occlusions. Recent Adv Stud Cardiac Struct Metab (1975) 0.77
Intracellular myocardial pH measured in vivo with sustained and reperfused coronary occlusion. Surgery (1987) 0.77
Effects of prostacyclin (PGI2) on vulnerability to ventricular fibrillation in the normal and ischemic canine heart. Eur J Pharmacol (1982) 0.77
Evidence for a reexcitability gap in man after treatment with type I antiarrhythmic drugs. Am Heart J (1993) 0.77
Effectiveness of propranolol added to a type I antiarrhythmic agent for sustained ventricular tachycardia secondary to coronary artery disease. Am J Cardiol (1990) 0.77
The effect of bretylium and clofilium on dispersion of refractoriness and vulnerability to ventricular fibrillation in the ischemic feline heart. Am Heart J (1985) 0.77